agilon health's (AGL) "Hold" Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of agilon health (NYSE:AGL - Free Report) in a research report report published on Friday,Benzinga reports.

Several other analysts also recently issued reports on the stock. Stifel Nicolaus lifted their price target on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research report on Wednesday, February 26th. Macquarie began coverage on shares of agilon health in a report on Monday, December 16th. They set a "neutral" rating and a $3.00 price objective for the company. Sanford C. Bernstein upped their target price on shares of agilon health from $2.50 to $3.15 and gave the stock a "market perform" rating in a report on Wednesday, January 15th. Royal Bank of Canada lifted their price target on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Finally, Citigroup raised agilon health from a "sell" rating to a "neutral" rating and boosted their price objective for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, agilon health has a consensus rating of "Hold" and a consensus target price of $3.95.

Remove Ads

agilon health Stock Up 2.4 %

Shares of NYSE AGL traded up $0.11 during trading on Friday, hitting $4.64. 1,298,246 shares of the company traded hands, compared to its average volume of 5,772,262. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The business's fifty day moving average is $3.51 and its 200 day moving average is $2.94. The firm has a market capitalization of $1.91 billion, a price-to-earnings ratio of -4.94 and a beta of 0.67. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73.

Hedge Funds Weigh In On agilon health

Several institutional investors have recently added to or reduced their stakes in AGL. Wealth Enhancement Advisory Services LLC purchased a new position in agilon health in the fourth quarter valued at about $155,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in agilon health by 24.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company's stock valued at $1,516,000 after purchasing an additional 157,610 shares during the last quarter. Two Sigma Advisers LP grew its holdings in agilon health by 4,393.5% during the fourth quarter. Two Sigma Advisers LP now owns 480,800 shares of the company's stock valued at $914,000 after purchasing an additional 470,100 shares during the period. Two Sigma Investments LP grew its holdings in agilon health by 73.7% during the fourth quarter. Two Sigma Investments LP now owns 857,867 shares of the company's stock valued at $1,630,000 after purchasing an additional 363,855 shares during the period. Finally, State of Wyoming increased its position in agilon health by 89.3% in the fourth quarter. State of Wyoming now owns 122,504 shares of the company's stock worth $233,000 after buying an additional 57,802 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.